Endometrial Receptivity Test
AI-Powered Receptivity Testing
Confirm Endometrial Readiness with AI-Powered Receptivity Testing
If you’re navigating IVF, you already know that every detail of your cycle matters. You’ve made the appointments, taken the medications, and waited. When it comes to embryo transfer, ensuring the uterine environment is prepared for implantation is a critical step in the journey.
Endometrial receptivity testing helps your care team better understand whether your body is ready, at that specific point in your cycle, for an embryo to implant.
AIM builds on decades of clinical research and introduces a more data-driven approach. Using advanced imaging analysis and machine learning, it helps clinicians assess endometrial receptivity within your current cycle—without requiring an invasive procedure.
What is an Endometrial Receptivity Test?
An endometrial receptivity test evaluates whether the lining of your uterus (the endometrium) is in a state that can support embryo implantation.
Think of it like preparing the soil before planting a seed. The conditions need to be right for the embryo to take root. In the body, this state of endometrial readiness is known as receptivity, and the timing of this phase can vary from person to person.
Understanding what endometrial receptivity is helps ensure that the decision to proceed with a transfer is backed by data from your body’s current state.
Why Endometrial Receptivity Testing Is Critical for IVF Success
Successful implantation depends on two key factors: embryo quality and the endometrial condition at the time of transfer.
Even with high-quality embryos, implantation may not occur if the embryo is placed in a sub-optimal environment. By incorporating an endometrial receptivity test, clinicians can better inform the decision to proceed with a transfer and support more personalized treatment plans.
How AIM’s Endometrial Receptivity Test Works
AIM is designed to fit seamlessly into existing IVF protocols—without adding extra procedures or patient burden.
Step 1: Ultrasound Image Collection
During a routine monitoring appointment, a standard 2D ultrasound is performed. No biopsy or additional intervention is required.
Step 2: AI-Powered Analysis
These images are securely analyzed using AIM’s computational platform, which evaluates subtle structural and textural features that indicate receptivity—details that are not possible to quantify through visual assessment alone.
Step 3: Personalized Receptivity Score
AIM generates a personalized endometrial receptivity score, giving clinicians a clearer understanding of the endometrium’s status at that point in the cycle.
Step 4: Informed Decision-Making
Using this information, clinicians can determine whether the endometrium has reached the necessary state of readiness to proceed with the embryo transfer in the current cycle.
Why Choose AIM, The Non-Invasive Endometrial Receptivity Test
One of the most important differences with AIM is its non-invasive approach.
Traditional methods, such as the ERA (Endometrial Receptivity Array), require an endometrial biopsy, which is typically performed in a separate “mock” cycle. This can add time, cost, and physical discomfort.
AIM uses ultrasound data already collected during routine care. That means no biopsy, no additional recovery time, and no need to wait for a future cycle to gain insights into your current readiness.
AIM vs Traditional Endometrial Receptivity Testing Methods
ERA represents an important step forward in evaluating the endometrium, but it relies on tissue sampling and provides insight based on a prior cycle.
AIM offers a non-invasive alternative that analyzes imaging data from the current cycle, enabling clinicians to evaluate endometrial receptivity in real time during ongoing treatment.
Benefits of AIM's Endometrial Receptivity Testing
Benefits for Fertility Clinics
- Consistent analysis with reduced subjectivity in ultrasound interpretation
- Efficient workflow with no additional procedures or hardware required
- Evidence-based support built on decades of peer-reviewed research
Benefits for IVF Patients
- Non-invasive approach with no biopsy required
- Live-cycle-specific insights based on your actual treatment cycle
- Greater clarity and confidence before proceeding with embryo transfer
Get Started with Endometrial Receptivity Testing
If you’re preparing for an embryo transfer, understanding your body’s readiness can make a meaningful difference. AIM provides clinicians with additional insight into endometrial receptivity, helping guide decisions with more confidence and precision.
Who Should Consider an AIM Endometrial Receptivity Test?
For All Patients Undergoing an IVF Cycle
- Because AIM is currently the only non-invasive test that accurately assesses endometrial receptivity in real time, every patient going through an IVF cycle can benefit. It provides deep insight into your current cycle’s readiness, offering clarity before proceeding with an embryo transfer.
For Fertility Clinics Treating IVF Patients
- Clinics can use AIM to support more consistent and data-informed assessments of endometrial readiness.
- It integrates into existing fertility clinic workflows and does not require new equipment.
FAQs
Is an endometrial receptivity test painful?
- No. AIM is non-invasive and uses standard ultrasound imaging, so it feels the same as a routine monitoring appointment.
How accurate is the AIM endometrial receptivity test?
- AIM’s models have been developed and validated using thousands of annotated ultrasound images, demonstrating high-performance accuracy in identifying key markers of endometrial readiness.
How long does it take to get receptivity test results?
- Results are typically available shortly after image analysis, allowing clinicians to make informed decisions within the same treatment cycle.
Do fertility clinics need special equipment to use AIM?
- No. AIM is a software-based platform designed to work with existing ultrasound systems, so no additional hardware is required.